These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 2893531

  • 1. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
    Norris RJ.
    Am J Cardiol; 1988 Feb 10; 61(5):14C-22C. PubMed ID: 2893531
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
    Milne RJ, Buckley MM.
    Drugs; 1991 Jun 10; 41(6):941-69. PubMed ID: 1715268
    [Abstract] [Full Text] [Related]

  • 6. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G, Ravogli A, Bragato R, Omboni S, Mutti E, Mancia G.
    J Cardiovasc Pharmacol; 1989 Jun 10; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [Abstract] [Full Text] [Related]

  • 7. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.
    Riddell JG, Shanks RG, Brogden RN.
    Drugs; 1987 Oct 10; 34(4):438-58. PubMed ID: 2890513
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.
    DiNicolantonio JJ, Hackam DG.
    Expert Rev Cardiovasc Ther; 2012 Jan 10; 10(1):13-25. PubMed ID: 22149523
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Celiprolol--overview of 6 years of clinical trials experience.
    Pruss TP, Lamon KD, Hagen NS.
    J Int Med Res; 1988 Jan 10; 16 Suppl 1():17A-22A. PubMed ID: 2906015
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacology of celiprolol.
    Louis WJ, Drummer OH, Tung LH.
    Cardiovasc Drugs Ther; 1991 Jan 10; 4 Suppl 6():1281-5. PubMed ID: 1672604
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
    Doshan HD, Rosenthal RR, Brown R, Slutsky A, Applin WJ, Caruso FS.
    J Cardiovasc Pharmacol; 1986 Jan 10; 8 Suppl 4():S105-8. PubMed ID: 2427836
    [Abstract] [Full Text] [Related]

  • 19. [Celiprolol].
    Galende I, Suárez JR, Azanza JR, Honorato J.
    Rev Med Univ Navarra; 1988 Jan 10; 32(4):229-32. PubMed ID: 2908736
    [No Abstract] [Full Text] [Related]

  • 20. Clinical experience with dual-acting drugs in hypertension.
    Rahn KH.
    Clin Investig; 1992 Jan 10; 70 Suppl 1():S39-42. PubMed ID: 1350483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.